Makers Of Over-the-Counter Inhaler Leading Fight To Have Product Back On … – MarketWatch (press release)

Makers Of Over-the-Counter Inhaler Leading Fight To Have Product Back On
MarketWatch (press release)
Before the ban, two to three million asthma sufferers in the United States relied on Primatene® Mist, because they did not have health insurance or the means to pay for a doctor's visit to get a prescription, or simply because they preferred Primatene

and more »

View full post on asthma – Google News

FDA: Over-the-counter asthma inhalers containing chloroflouorocarbons (CFCs … – MMD Newswire (press release)

FDA: Over-the-counter asthma inhalers containing chloroflouorocarbons (CFCs
MMD Newswire (press release)
Epinephrine inhalers, marketed by Armstrong Pharmaceutical Inc. as Primatene Mist, are the only FDA-approved inhalers for the temporary relief of occasional symptoms of mild asthma that are sold over-the-counter in retail stores without a prescription.
FDA: Over-the-Counter Asthma Inhalers Containing Chloroflouorocarbons (CFCs MarketWatch (press release)

all 7 news articles »

View full post on asthma – Google News

FDA: Over-the-Counter Asthma Inhaler Will Not Be Sold After Dec. 31 – Fox News


Fox News

FDA: Over-the-Counter Asthma Inhaler Will Not Be Sold After Dec. 31
Fox News
The US Food and Drug Administration said the only over-the-counter asthma inhaler sold in the US will no longer be available after December 31, 2011. The action was taken because Primatene Mist uses chlorofluorocarbons (CFCs), which deplete the ozone
Health Highlights: March 17, 2011U.S. News & World Report
FDA to Pull Only OTC Epinephrine Asthma Inhaler at Year-EndProHealth
Only OTC asthma inhaler to be withdrawn from marketClinical Advisor
CalorieLab Calorie Counter News
all 8 news articles »

View full post on asthma – Google News